UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000047711
Receipt number R000054391
Scientific Title Effects of Antimicrobial Peptides Application after Non-surgical Periodontal Therapy on Treatment of Stage III and Grade B Periodontitis: A Randomized Clinical and Microbiological Trial
Date of disclosure of the study information 2022/06/01
Last modified on 2022/05/10 21:30:06

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Effects of Antimicrobial Peptides Application after Non-surgical Periodontal Therapy on Treatment of Stage III and Grade B Periodontitis: A Randomized Clinical and Microbiological Trial

Acronym

AMPs

Scientific Title

Effects of Antimicrobial Peptides Application after Non-surgical Periodontal Therapy on Treatment of Stage III and Grade B Periodontitis: A Randomized Clinical and Microbiological Trial

Scientific Title:Acronym

AMPs

Region

Asia(except Japan)


Condition

Condition

In this randomized clinical trial, we aimed to evaluate the effects of AMPs as an addition to SRP on clinical parameters and microbiological biofilms in patients with Stage III and Grade B periodontitis.

Classification by specialty

Infectious disease Surgery in general Oral surgery
Dental medicine Adult

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To evaluate the effects of the antimicrobial peptides (AMPs) as an adjunct to scaling and root planning (SRP) on clinical and microbiological outcomes in patients with periodontitis in Stage III and Grade B.

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1

Confirmatory

Trial characteristics_2

Explanatory

Developmental phase

Phase III


Assessment

Primary outcomes

probing depth,clinical attachment level,Bleeding index, and Microbiological results

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Single blind -participants are blinded

Control

Dose comparison

Stratification

YES

Dynamic allocation

YES

Institution consideration

Institution is considered as a block.

Blocking

NO

Concealment

Pseudo-randomization


Intervention

No. of arms

2

Purpose of intervention

Treatment

Type of intervention

Medicine

Interventions/Control_1

SRP with AMPs group (AMP group)/SRP group

Interventions/Control_2

SRP with AMPs group (AMP group)/SRP with minocycline hydrochloride group (Perio group)

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

65 years-old >=

Gender

Male and Female

Key inclusion criteria

The inclusion criteria were: (1) at least 20 years old, (2) previously untreated Stage III and Grade B periodontitis by clinically and radiologically17, (3) a minimum of 20 natural teeth in the mouth, and more than 4 molars.

Key exclusion criteria

The exclusion criteria were: (1) acute oral lesions or necrotizing ulcerative periodontitis, (2) having received antibiotics within 6 months or the need for antibiotic coverage during experiment, (3) being allergic to minocycline, (4) no orthodontic treatment, (5) a history of systemic diseases, (6) pregnancy, (7) smoker

Target sample size

51


Research contact person

Name of lead principal investigator

1st name Shuchang
Middle name
Last name Xiang

Organization

School of Stomatology, Capital Medical University

Division name

CCMU

Zip code

100050

Address

Tian Tan Xi Li No.4

TEL

86-10-57099450

Email

qhddenver@126.com


Public contact

Name of contact person

1st name Nannan
Middle name
Last name Han

Organization

Beijing Stomatological Hospital, Capital Medical University

Division name

CCMU

Zip code

100050

Address

Tian Tan Xi Li No.4

TEL

86-10-57099450

Homepage URL


Email

morose2012@sina.cn


Sponsor or person

Institute

Department of Periodontics,Beijing Stomatological Hospital, Capital Medical University

Institute

Department

Personal name



Funding Source

Organization

National Nature Science Foundation of China, the Discipline Construction Fund of Beijing Stomatological Hospital, Beijing Stomatological Hospital, Capital Medical University Young Scientist Program .

Organization

Division

Category of Funding Organization

Outside Japan

Nationality of Funding Organization

China


Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Beijing Stomatological Hospital, Capital Medical University

Address

Tian Tan Xi Li No.4

Tel

86-10-57099450

Email

morose2012@sina.cn


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

Beijing Stomatological Hospital, Capital Medical University


Other administrative information

Date of disclosure of the study information

2022 Year 06 Month 01 Day


Related information

URL releasing protocol

https://wiley.atyponrex.com/dashboard

Publication of results

Unpublished


Result

URL related to results and publications

https://wiley.atyponrex.com/dashboard

Number of participants that the trial has enrolled

51

Results

Probing depth:the reduction was significantly higher in the AMP group than in the other two groups (p<0.001).
Attachment level and Bleeding index: The AMP group at 90 days not only showed an increase in attachment gain and reduction in the bleeding index compared with the baseline of this group but also showed a significantly higher increase than the other two groups (p< 0.05).

Results date posted

2022 Year 05 Month 10 Day

Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics

patients with Stage III and Grade B Periodontitis

Participant flow

https://wiley.atyponrex.com/dashboard

Adverse events

no

Outcome measures

https://wiley.atyponrex.com/dashboard

Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Open public recruiting

Date of protocol fixation

2018 Year 03 Month 01 Day

Date of IRB

2018 Year 07 Month 01 Day

Anticipated trial start date

2018 Year 03 Month 01 Day

Last follow-up date

2018 Year 07 Month 01 Day

Date of closure to data entry

2018 Year 07 Month 07 Day

Date trial data considered complete

2018 Year 08 Month 01 Day

Date analysis concluded

2019 Year 11 Month 01 Day


Other

Other related information



Management information

Registered date

2022 Year 05 Month 10 Day

Last modified on

2022 Year 05 Month 10 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000054391


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name